Primary Progressive Multiple Sclerosis
Showing 26 - 50 of >10,000
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Relapsing Multiple Sclerosis Trial in Boston
Recruiting
- Primary Progressive Multiple Sclerosis
- +3 more
-
Boston, MassachusettsBrigham and Women's Hospital
Jul 20, 2021
Multiple Sclerosis, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in San Francisco
Recruiting
- Multiple Sclerosis
- +2 more
- N-acetyl cysteine
- Placebo
-
San Francisco, CaliforniaUniversity of California, San Francisco
Mar 22, 2022
Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Secondary Progressive Trial in Marseille, Rennes (Magnetic
Recruiting
- Multiple Sclerosis, Primary Progressive
- Multiple Sclerosis, Secondary Progressive
- Magnetic Resonance Imaging
- +3 more
-
Marseille, France
- +1 more
Jan 14, 2022
Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial
Recruiting
- Relapsing Remitting Multiple Sclerosis
- +2 more
- Rituximab
- +4 more
-
Glostrup, Copenhagen, Denmark
- +11 more
May 3, 2022
Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Primary Progressive Trial in Kaposvár (Training groupe, PNF,
Completed
- Multiple Sclerosis, Chronic Progressive
- Multiple Sclerosis, Primary Progressive
- Training groupe
- +3 more
-
Kaposvár, Somogy, HungarySomogy Megyei Kaposi Mór Oktató Kórház
Mar 24, 2022
Multiple Sclerosis, Chronic Progressive, Multiple Sclerosis, Multiple Sclerosis, Primary Progressive Trial in Porto Alegre
Not yet recruiting
- Multiple Sclerosis, Chronic Progressive
- +3 more
- Nordic Walking (NWG)
- +2 more
-
Porto Alegre, Rio Grande Do Sul, BrazilUniversidade Federal do Rio Grande do Sul
May 17, 2022
Primary Progressive Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in Australia, Canada, United States
Active, not recruiting
- Primary Progressive Multiple Sclerosis
- Secondary Progressive Multiple Sclerosis
- ATA188
- Placebo
-
La Jolla, California
- +33 more
Jul 21, 2022
Primary Progressive Multiple Sclerosis Trial in Copenhagen (Dimethyl fumarate, Placebo)
Completed
- Primary Progressive Multiple Sclerosis
- Dimethyl fumarate
- Placebo
-
Copenhagen, DenmarkDanish Multiple Sclerosis Center, Department of neurology
Dec 22, 2020
Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Dublin (Fampridine, Placebo)
Completed
- Secondary Progressive Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Fampridine
- Placebo
-
Dublin, Dublin 4, Ireland
- +1 more
Jul 8, 2021
MS-ResearchBiomarkerS
Recruiting
- Multiple Sclerosis
- +10 more
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Jan 26, 2022
Multiple Sclerosis, Relapsing-Remitting, Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis, Primary Progressive
Completed
- Multiple Sclerosis, Relapsing-Remitting
- +2 more
- Insulin
- Placebo (Sterile diluent)
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Dec 30, 2021
Relapsing Multiple Sclerosis, Primary Progressive Multiple Sclerosis Trial in Worldwide (Ocrelizumab IV, Ocrelizumab SC,
Active, not recruiting
- Relapsing Multiple Sclerosis
- Primary Progressive Multiple Sclerosis
- Ocrelizumab IV
- +5 more
-
Tampa, Florida
- +46 more
Jan 13, 2023
Multiple Sclerosis, Progressive Multiple Sclerosis Trial in Bergen (Nicotinamid riboside, Placebo)
Not yet recruiting
- Multiple Sclerosis
- Progressive Multiple Sclerosis
- Nicotinamid riboside
- Placebo
-
Bergen, NorwayHaukeland University Hospital
Feb 22, 2023
Progressive Multiple Sclerosis Trial in Thessaloniki (Early Harvest Extra Virgin Olive Oil)
Completed
- Progressive Multiple Sclerosis
- Early Harvest Extra Virgin Olive Oil
-
Thessaloniki, Macedonia, GreeceA' Department of Neurology,Aristotle University of Thessaloniki
Jul 4, 2021
Neurologic Disorders, Nervous System Diseases, Neurodegenerative Diseases Trial in Westport, Coral Springs, Dubai (Intravenous
Recruiting
- Neurologic Disorders
- +25 more
- Intravenous and Intranasal BMSC
-
Westport, Connecticut
- +2 more
Nov 25, 2022
Multiple Sclerosis Trial in Berlin (Sunphenon EGCG, Placebo)
Completed
- Multiple Sclerosis
- Sunphenon EGCG
- Placebo
-
Berlin, GermanyCharité Universitätsmedizin Berlin (NeuroCure Clinical Research
Jul 28, 2021
Progressive Multiple Sclerosis Trial (Transcranial static magnetic field stimulation (tSMS), Sham Transcranial static magnetic
Not yet recruiting
- Progressive Multiple Sclerosis
- Transcranial static magnetic field stimulation (tSMS)
- Sham Transcranial static magnetic field stimulation (tSMS)
- (no location specified)
Mar 30, 2023
Multiple Sclerosis, Secondary Progressive, Multiple Sclerosis Trial in Warsaw (Cladribine Subcutaneous Injection, 0.9% Chloride
Recruiting
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis
- Cladribine Subcutaneous Injection
- 0.9% Chloride Injection Sodium
-
Warsaw, Mazowieckie, PolandInstitute of Psychiatry and Neurology
Jul 26, 2023
Visual Processing Speed and Objective Analysis of Ocular
Enrolling by invitation
- Multiple Sclerosis
- +3 more
- Eye tracking
- +3 more
-
Valladolid, SpainIOBA - Universidad de Valladolid
Jan 20, 2023
Progressive Multiple Sclerosis Trial in Ghent (Bytelfies kit - sensor dot)
Recruiting
- Progressive Multiple Sclerosis
- Bytelfies kit - sensor dot
-
Ghent, Oost-Vlaanderen, BelgiumUniversity Hospital Ghent
Jan 5, 2023
Multiple Sclerosis, Progressive Multifocal Leukoencephalopathy Trial run by the National Institute of Neurological Disorders and
Not yet recruiting
- Multiple Sclerosis
- Progressive Multifocal Leukoencephalopathy
- 89 Zr-Df-crefmirlimab
-
Bethesda, MarylandNational Institutes of Health Clinical Center
May 13, 2023
Cortical Lesions in Patients With Multiple Sclerosis
Completed
- Multiple Sclerosis
- +2 more
-
Hvidovre, DenmarkDanish Research Centre for Magnetic Resonance
Apr 6, 2021
Microglia in the Pathogenesis of Progressive Multiple Sclerosis
Active, not recruiting
- Multiple Sclerosis
-
Turku, Finland Proper, FinlandTurku PET Centre
Oct 12, 2022
Progressive Multiple Sclerosis Trial in Genova, Roma (Osmotin)
Recruiting
- Progressive Multiple Sclerosis
- Osmotin
-
Genova, Italy
- +1 more
Jun 30, 2023